TGFA identified as key regulator in cervical cancer progression via DSG2 interaction
TGFA promotes cervical cancer progression by interacting with DSG2, enhancing cell proliferation and metastasis.
Asset / Drug
Drug and asset intelligence for DSG2 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.